Company profile
Home | Qkine
High purity, bioactive recombinant cytokine proteins and growth factors made for stem cell, organoid and regenerative medicine.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
TM02 | Transaction MzQzNDI4MDE1NWFkaXF6a2N4
Published 03 Sep 2024 09:35
Company registered at Companies House
Qkine develops substances designed to stimulate cellular growth in regenerative medicine applications.
Qkine uses proprietary protein purification and engineering technology to make the highest recombinant proteins for stem cell research and regenerative medicine applications.
The company has operated as a embedded company in Dr Hyvonen's laboratory for the past two years with two full time laboratory staff (one researcher and one research assistant), with Dr Hyvonen as the CSO of the company. The company has launced half a dozen products on the market with steady R&D pipeline expected to result on average one new product per month. The company was awarded an Innovagte UK grant in 2017 for the development of growth factors for organoid research. The company is just finishing its second funding round and expects to move to its own premises in late March/early April and have up to 5 scientific staff by the end of the year. The company is already trading and gaining traction in the market with sales both in UK and worldwide.
15 Apr 2025 to 15 Apr 2027
Qkine combines proprietary animal-free biomanufacturing processes with protein engineering technology. Leveraging our expertise and manufacturing process development platform, we will develop a unique animal-origin-free, high-purity TGF beta family product portfolio to accelerate stem cell science, overcome specific drug discovery barriers, and solve fund...
29 Mar 2021 to 29 Mar 2023
Organoids are 3-dimensional (3D) clusters of stem cells that come together and emulate the microenvironment within individual organs, whether that be liver, kidney, heart, gut or other specific organs. Essentially, they can be viewed as miniature, simplified organs. They typically range in size from a few micrometers to five millimeters and there are pote...
1 Jan 2021 to 30 Sep 2021
Organoids are 3-dimensional (3D) clusters of stem cells that come together and emulate the microenvironment within individual organs, whether that be liver, kidney, heart, gut or other specific organs. Essentially, they can be viewed as miniature, simplified organs. They typically range in size from a few micrometers to five millimeters and there are pote...
1 Dec 2017 to 30 Nov 2018
One of the most exciting developments in biological research is the development of miniature three-dimensional structures that mimic mammalian organs such as gut, pancreas, lung and, in the case of cancer, tumours. These so-called organoids allow us to study the structure, development and function of these organs in highly controlled environment and most ...
